143 related articles for article (PubMed ID: 36611881)
1. Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression.
Yamada K; Saito M; Ando M; Abe T; Mukoyama T; Agawa K; Watanabe A; Takamura S; Fujita M; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Kakeji Y; Yamashita K
Cells; 2022 Dec; 12(1):. PubMed ID: 36611881
[TBL] [Abstract][Full Text] [Related]
2. Probiotics Can Boost the Antitumor Immunity of CD8
Mao J; Zhang SZ; Du P; Cheng ZB; Hu H; Wang SY
J Immunol Res; 2020; 2020():4092472. PubMed ID: 32455139
[TBL] [Abstract][Full Text] [Related]
3. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
4. Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.
Omori R; Eguchi J; Hiroishi K; Ishii S; Hiraide A; Sakaki M; Doi H; Kajiwara A; Ito T; Kogo M; Imawari M
Cancer Gene Ther; 2012 Sep; 19(9):637-43. PubMed ID: 22790963
[TBL] [Abstract][Full Text] [Related]
5. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
[TBL] [Abstract][Full Text] [Related]
6. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
7. Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4
Matsubara Y; Ota Y; Tanaka Y; Denda T; Hijikata Y; Boku N; Lim LA; Hirata Y; Tsurita G; Adachi E; Yotsuyanagi H
Int J Clin Oncol; 2022 Aug; 27(8):1321-1330. PubMed ID: 35643870
[TBL] [Abstract][Full Text] [Related]
8. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
9. Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer.
Xu Y; Wang H; Wang T; Chen C; Sun R; Yao W; Ma Y; Zhang Q; Wu L; Zeng S; Sun X
Cancer Sci; 2022 May; 113(5):1739-1751. PubMed ID: 35238098
[TBL] [Abstract][Full Text] [Related]
10. Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency.
Khan IM; Dai Perrard XY; Perrard JL; Mansoori A; Wayne Smith C; Wu H; Ballantyne CM
Atherosclerosis; 2014 Apr; 233(2):419-428. PubMed ID: 24530773
[TBL] [Abstract][Full Text] [Related]
11. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
Lu L; Xu X; Zhang B; Zhang R; Ji H; Wang X
J Transl Med; 2014 Feb; 12():36. PubMed ID: 24502656
[TBL] [Abstract][Full Text] [Related]
12. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
Guo Z; Wang H; Meng F; Li J; Zhang S
J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
Lussier DM; Woolf EC; Johnson JL; Brooks KS; Blattman JN; Scheck AC
BMC Cancer; 2016 May; 16():310. PubMed ID: 27178315
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice.
Guo X; Xu Y; Luo W; Fang R; Cai L; Wang P; Zhang Y; Wen Z; Xu Y
BMC Pediatr; 2021 Jul; 21(1):317. PubMed ID: 34271894
[TBL] [Abstract][Full Text] [Related]
15. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
16. Expression of B7-H2 on CD8
Cao Y; Cao T; Zhao W; He F; Lu Y; Zhang G; Hu H; Wang Z
Int Immunopharmacol; 2018 Mar; 56():128-134. PubMed ID: 29414642
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer.
Ding G; Shen T; Yan C; Zhang M; Wu Z; Cao L
BMC Cancer; 2019 Nov; 19(1):1053. PubMed ID: 31694582
[TBL] [Abstract][Full Text] [Related]
18. Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment.
Aoyama S; Nakagawa R; Nemoto S; Perez-Villarroel P; Mulé JJ; Mailloux AW
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135102
[TBL] [Abstract][Full Text] [Related]
19. Caffeine-enhanced anti-tumor immune response through decreased expression of PD1 on infiltrated cytotoxic T lymphocytes.
Venkata Charan Tej GN; Neogi K; Verma SS; Chandra Gupta S; Nayak PK
Eur J Pharmacol; 2019 Sep; 859():172538. PubMed ID: 31310752
[TBL] [Abstract][Full Text] [Related]
20. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
